pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 30·1 min read
save

Anthropic launches Claude Science AI platform tailored for pharmaceutical research

Jun 30, 2026·read at STAT ↗Positive

Anthropic announced the availability of Claude Science, an AI application built on its large language model and aimed at scientific laboratories and pharmaceutical research.

The tool is intended to help scientists manage the complexity of biology by assisting with data analysis, hypothesis generation and literature review, according to company executives.

The company describes the product as a general-purpose technology for life-science research, but notes that its real-world impact remains to be demonstrated as it is adopted by customers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Anthropic releases Claude Science, a product aimed at researchers, the pharma industry”

read at STAT ↗
531 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Gene Therapy (AAV)

related stories

  • May 4UCB to acquire maker of antibody treatments for autoimmune diseasesSTAT
  • May 4STAT+: Biotech raises $42 million to run Huntington’s disease trialSTAT
  • Apr 30STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics centerSTAT
  • Apr 30UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapyBioPharma Dive
  • Apr 30STAT+: Five-way obesity drug is super effective — in miceSTAT